Literature DB >> 21114613

Relation between pain and skeletal metastasis in patients with prostate or breast cancer.

Gabriella Levren1, May Sadik, Peter Gjertsson, Milan Lomsky, Annika Michanek, Lars Edenbrandt.   

Abstract

The aim of this study was to examine the relation between pain and bone metastases in a group of patients with prostate or breast cancer that had been referred for bone scintigraphy. Whole-body bone scans, anterior and posterior views obtained with a dual detector gamma camera were studied from 101 consecutive patients who had undergone scintigraphy (600 MBq Tc-99m MDP) because of suspected bone metastatic disease. At the time of the examination, all patients were asked whether they felt any pain or had recently a trauma. This information was correlated with the classifications regarding the presence or absence of bone metastases made by a group of three experienced physicians. In patients with prostate cancer, we found metastases in 47% (18/38) of the patients with pain, but only in 12% (2/17) of the patients without pain (p = 0.01). In patients with breast cancer, on the other hand, metastases were more common in patients without pain (71%; 10/14) than in patients with pain (34%; 11/32) (p = 0.02). In conclusion, a significant relation between pain and skeletal metastases could be found in patients with prostate cancer and a reverse relation in patients with breast cancer.
© 2010 The Authors. Clinical Physiology and Functional Imaging © 2010 Scandinavian Society of Clinical Physiology and Nuclear Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114613     DOI: 10.1111/j.1475-097X.2010.00999.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  2 in total

1.  Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale.

Authors:  Ramy Sedhom; Emmanuel S Antonarakis
Journal:  Transl Androl Urol       Date:  2019-07

2.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.